Merck Stock Analysis


USD 107.50  0.95  0.88%   

The recent price surge of Merck Company may encourage traders to take a closer look at the firm as it is trading at a share price of 107.50 on 3,163,683 in trading volume. The company executives may have good odds in positioning the firm resources to exploit market volatility in December. The stock standard deviation of daily returns for 90 days investing horizon is currently 1.35. The below-average Stock volatility is a good sign for longer-term investment options and for buy-and-hold investors.
Additionally, see Correlation Analysis.
The Merck stock analysis report makes it easy to digest most publicly released information about Merck and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Merck Stock analysis module also helps to analyze the Merck price relationship with some important fundamental indicators such as market cap and management efficiency.

Merck Stock Analysis Notes

About 76.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 1.23. Merck Company recorded earning per share (EPS) of 6.03. The entity last dividend was issued on the 14th of September 2022. The firm had 2:1 split on the 3rd of June 2021. Merck Co., Inc. operates as a healthcare company worldwide. Merck Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey. Merck operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 67000 people. To find out more about Merck Company contact Kenneth Frazier at 908 735-1500 or learn more at

Merck Company Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Merck's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Merck Company or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Over 76.0% of the company shares are owned by institutional investors
On 7th of October 2022 Merck paid $ 0.69 per share dividend to its current shareholders
Latest headline from Merck Co., Inc. insiders sold US3.0m worth of stock, a possible red flag thats yet to materialize - Yahoo Finance

Merck Company Upcoming and Recent Events

Earnings reports are used by Merck to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Merck previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report3rd of February 2022
Next Financial Report5th of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End3rd of February 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Merck Largest EPS Surprises

Earnings surprises can significantly impact Merck's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Fiscal Date
Estimated EPS
Reported EPS
View All Earnings Estimates

Merck SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Merck prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Merck investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Merck Company specific information freely available to individual and institutional investors to make a timely investment decision.
28th of July 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
26th of May 2022
Submission of Matters to a Vote of Security Holders
28th of April 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
20th of April 2022
Financial Statements and Exhibits. Other Events. Results of Operations and Financial Condition
25th of March 2022
Financial Statements and Exhibits. Amendments to Articles of Incorporation or Bylaws; and/or Change in Fiscal Year
9th of February 2022
Unclassified Corporate Event
3rd of February 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
2nd of February 2022
Unclassified Corporate Event

Merck Thematic Classifications

In addition to having Merck stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Robots And Drones
Cross-sector firms and funds that develop or invest in technology that can replicate repetitive human actions
Addiction driven consumer products and services
Giant Impact
Public companies with mega capitalization
Drug manufacturing and delivery

Merck Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Merck is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Merck Company backward and forwards among themselves. Merck's institutional investor refers to the entity that pools money to purchase Merck's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Zwj Investment Counsel IncCommon Shares294.9 K25.4 M
Zwj Investment Counsel IncCommon Shares323.7 K29.5 M
Zwj Investment Counsel IncCommon Shares365.6 K30 M
Zwj Investment Counsel IncCommon Shares373.9 K28.7 M
Zwj Investment Counsel IncCommon Shares373.8 K28.1 M
Zwj Investment Counsel IncCommon Shares378.8 K29.5 M
Zwj Investment Counsel IncCommon Shares394.3 K30.4 M
Note, although Merck's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Merck Market Capitalization

The company currently falls under 'Mega-Cap' category with total capitalization of 271.03 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Merck's market, we take the total number of its shares issued and multiply it by Merck's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Merck Profitablity

Merck's profitability indicators refer to fundamental financial ratios that showcase Merck's ability to generate income relative to its revenue or operating costs. If, let's say, Merck is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Merck's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Merck's profitability requires more research than a typical breakdown of Merck's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Net Profit Margin of 25.88 %, which may imply that it executes well on its competitive polices and has reasonable control over its expenses and variable costs. This is very large. In the same way, it shows Net Operating Margin of 40.82 %, which entails that for every 100 dollars of revenue, it generated 0.41 of operating income.
Last ReportedProjected for 2022
Return on Investment 19.53  21.07 
Return on Average Assets 13.23  14.27 
Return on Average Equity 41.10  44.34 
Return on Invested Capital 0.26  0.23 
Return on Sales 0.30  0.28 

Management Efficiency

The entity has Return on Asset of 12.68 % which means that on every $100 spent on asset, it made $12.68 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 38.14 %, implying that it generated $38.14 on every 100 dollars invested. Merck management efficiency ratios could be used to measure how well merck company manages its routine affairs as well as how well it operates its assets and liabilities. Merck Return on Investment is increasing as compared to previous years. The last year's value of Return on Investment was reported at 19.53. The current Return on Average Assets is estimated to increase to 14.27, while Return on Invested Capital is projected to decrease to 0.23. Merck Liabilities Non Current is increasing as compared to previous years. The last year's value of Liabilities Non Current was reported at 43.56 Billion. The current Tax Liabilities is estimated to increase to about 5.1 B, while Total Liabilities is projected to decrease to under 59.2 B.
Last ReportedProjected for 2022
Book Value per Share 15.12  14.01 
Enterprise Value over EBIT 14.00  20.79 
Enterprise Value over EBITDA 11.81  14.01 
Price to Book Value 5.07  5.41 
Tangible Assets Book Value per Share 24.35  25.36 
Enterprise Value210 B216 B
Tangible Asset Value61.5 B57.5 B

Technical Drivers

As of the 29th of November, Merck secures the Downside Deviation of 1.28, risk adjusted performance of 0.309, and Mean Deviation of 1.08. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Merck Company, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to interpolate data for nineteen technical drivers for Merck, which can be compared to its peers in the industry. Please verify Merck Company variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if Merck Company is priced some-what accurately, providing market reflects its recent price of 107.5 per share. Given that Merck Company has jensen alpha of 0.278, we recommend you to check Merck's last-minute market performance to make sure the company can sustain itself at a future point.

Merck Company Price Movement Analysis

The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Mid-point over period is an average of Merck Company highest and lowest values attained during the given period.

Merck Company Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Merck insiders, such as employees or executives, is commonly permitted as long as it does not rely on Merck's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Merck insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Peter Wendell over a month ago via Macroaxis 
Merck exotic insider transaction detected
Kenneth Frazier over three months ago via Macroaxis 
Acquisition by Kenneth Frazier of 28532 shares of Merck subject to Rule 16b-3
David Williams over three months ago via Macroaxis 
Acquisition by David Williams of 17119 shares of Merck subject to Rule 16b-3
Arpa Garay over six months ago via Macroaxis 
Exercise or conversion by Arpa Garay of 773 shares of Merck subject to Rule 16b-3
Oosthuizen Johannes Jacobus over six months ago via Macroaxis 
Merck exotic insider transaction detected
Christine Seidman over six months ago via Macroaxis 
Acquisition by Christine Seidman of 198 shares of Merck subject to Rule 16b-3
Williams David Michael over six months ago via Macroaxis 
Acquisition by Williams David Michael of 1660 shares of Merck subject to Rule 16b-3
Williams David Michael over six months ago via Macroaxis 
Exercise or conversion by Williams David Michael of 1202 shares of Merck subject to Rule 16b-3
Williams David Michael over six months ago via Macroaxis 
Exercise or conversion by Williams David Michael of 1167 shares of Merck subject to Rule 16b-3
Kenneth Frazier over a year ago via Macroaxis 
Exercise or conversion by Kenneth Frazier of 663881 shares of Merck subject to Rule 16b-3
Julie Gerberding over a year ago via Macroaxis 
Exercise or conversion by Julie Gerberding of 11414 shares of Merck subject to Rule 16b-3
Frank Clyburn over a year ago via Macroaxis 
Exercise or conversion by Frank Clyburn of 19847 shares of Merck subject to Rule 16b-3

Merck Outstanding Bonds

Merck issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Merck Company uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Merck bonds can be classified according to their maturity, which is the date when Merck Company has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Merck Technical and Predictive Indicators

Merck Forecast Models

Merck time-series forecasting models is one of many Merck's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Merck's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Merck Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Merck prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Merck shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as Merck. By using and applying Merck Stock analysis, traders can create a robust methodology for identifying Merck entry and exit points for their positions.
Last ReportedProjected for 2022
Operating Margin 25.74  20.62 
EBITDA Margin 33.36  33.29 
Gross Margin 72.02  65.45 
Profit Margin 26.79  28.91 

Current Merck Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Merck analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Merck analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
Merck Company current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Merck analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Merck stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Merck Company, talking to its executives and customers, or listening to Merck conference calls.
Merck Analyst Advice Details

Merck Stock Analysis Indicators

Merck Company stock analysis indicators help investors evaluate how Merck stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Merck shares will generate the highest return on investment. By understating and applying Merck stock analysis, traders can identify Merck position entry and exit signals to maximize returns.
Quick Ratio0.95
Trailing Annual Dividend Rate2.72
Fifty Two Week Low71.50
Revenue Growth13.70%
Payout Ratio45.77%
Average Daily Volume Last 10 Day9.67M
Shares Short Prior Month20.4M
Average Daily Volume In Three Month8.88M
Earnings Growth-28.90%
Shares Percent Shares Out0.80%
Earnings Quarterly Growth-28.90%
Forward Price Earnings14.16
Short Percent Of Float0.80%
Float Shares2.53B
Fifty Two Week High107.10
Fifty Day Average93.69
Enterprise Value To Ebitda11.78
Two Hundred Day Average88.23
Enterprise Value To Revenue4.81
Trailing Annual Dividend Yield2.58%
Additionally, see Correlation Analysis. You can also try Analyst Recommendations module to analyst recommendations and target price estimates broken down by several categories.

Complementary Tools for analysis

When running Merck Company price analysis, check to measure Merck's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck is operating at the current time. Most of Merck's value examination focuses on studying past and present price action to predict the probability of Merck's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Merck's price. Additionally, you may evaluate how the addition of Merck to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Is Merck's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merck. If investors know Merck will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merck listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
Market Capitalization
272.6 B
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Merck Company is measured differently than its book value, which is the value of Merck that is recorded on the company's balance sheet. Investors also form their own opinion of Merck's value that differs from its market value or its book value, called intrinsic value, which is Merck's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merck's market value can be influenced by many factors that don't directly affect Merck's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merck's value and its price as these two are different measures arrived at by different means. Investors typically determine Merck value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merck's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.